# The Cigna Group – Consensus ‘buy’ rating and 14.9% Upside Potential

- Link: https://www.directorstalkinterviews.com/the-cigna-group-consensus-buy-rating-and-14.9-upside-potential/4121166227
- Published: 2024-07-26T13:06:00+01:00
- Author: Charlotte Edwards

**The Cigna Group** with ticker code (CI) now have 23 confirmed analysts covering
the stock with the consensus suggesting a rating of ‘buy’. The target price High/
Low ranges between $420.00 and $349.00 calculating the mean target price we have
$393.25. Now with the previous closing price of $342.21 this would imply there is
now a potential upside of 14.9%. The 50 day MA is $335.61 and the 200 day moving
average is $323.90. The market capitalization for the company is 96.91B. The stock
price for the company is currently $341.15 USD

 The potential market cap would be $111,366,059,341 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 28.01, revenue per share of $700.13
and a 3.08% return on assets.

The Cigna Group is a global health services company. The Company’s portfolio of 
offerings solves diverse challenges across the healthcare system. The Company offers
a differentiated set of pharmacy, medical, behavioral, dental and supplemental products,
and services, primarily through two platforms: Evernorth Health Services and Cigna
Healthcare. Evernorth Health Services includes a range of coordinated and point 
solution health services and capabilities, as well as those from partners across
the health care system, in pharmacy benefits, home delivery pharmacy, specialty 
pharmacy, distribution, and care delivery and management solutions, which are provided
to health plans, employers, government organizations and health care providers. 
Cigna Healthcare includes the United States Commercial, United States Government,
and International Health operating segments, which provide medical and coordinated
solutions to clients and customers.

Share on: